Bruker Corp
BRKR44.960USD
-0.710-1.55%
Handelsschluss 12/16, 16:00（ET）Kurse um 15 Minuten verzögert
6.81BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Bruker Corp Unternehmen
Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Bruker Corp Informationen
BörsenkürzelBRKR
Name des UnternehmensBruker Corp
IPO-datumAug 04, 2000
CEOPrause (Burkhard A)
Anzahl der mitarbeiter11396
WertpapierartOrdinary Share
GeschäftsjahresendeAug 04
Addresse40 Manning Rd
StadtBILLERICA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01821-3915
Telefon19786633660
Websitehttps://www.bruker.com/
BörsenkürzelBRKR
IPO-datumAug 04, 2000
CEOPrause (Burkhard A)
Führungskräfte von Bruker Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+0.08%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
+24.98%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
85.88K
+6.15%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+41.65%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+35.29%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
31.91K
+13.38%
Dr. Hermann Fritz Requardt, Ph.D.
Dr. Hermann Fritz Requardt, Ph.D.
Independent Director
Independent Director
23.15K
-3.83%
Ms. Adelene Q. Perkins
Ms. Adelene Q. Perkins
Independent Director
Independent Director
21.33K
-4.14%
Dr. Cynthia M. Friend, Ph.D.
Dr. Cynthia M. Friend, Ph.D.
Independent Director
Independent Director
14.72K
+5.48%
Ms. Bonnie H. Anderson
Ms. Bonnie H. Anderson
Independent Director
Independent Director
10.03K
-8.41%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+0.08%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
+24.98%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
85.88K
+6.15%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+41.65%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+35.29%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
31.91K
+13.38%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product
634.70M
79.60%
Product And Service Other
162.70M
20.40%
Service and other revenue
162.70M
20.40%
Nach RegionUSD
Name
Umsatz
Anteil
United States
222.90M
27.95%
Rest of Europe
213.40M
26.76%
Rest of Asia Pacific
127.40M
15.98%
China
114.70M
14.38%
Other
59.90M
7.51%
Germany
59.10M
7.41%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product
634.70M
79.60%
Product And Service Other
162.70M
20.40%
Service and other revenue
162.70M
20.40%
Aktionärsstatistik
Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Laukien (Frank H)
26.60%
Orbis Investment Management Ltd.
9.31%
Fidelity Management & Research Company LLC
7.52%
The Vanguard Group, Inc.
6.83%
Pallas Capital Advisors LLC
6.24%
Andere
43.50%
Aktionäre
Aktionäre
Anteil
Laukien (Frank H)
26.60%
Orbis Investment Management Ltd.
9.31%
Fidelity Management & Research Company LLC
7.52%
The Vanguard Group, Inc.
6.83%
Pallas Capital Advisors LLC
6.24%
Andere
43.50%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
50.95%
Individual Investor
31.97%
Investment Advisor/Hedge Fund
25.95%
Hedge Fund
8.24%
Research Firm
2.61%
Pension Fund
1.17%
Sovereign Wealth Fund
0.76%
Bank and Trust
0.38%
Insurance Company
0.21%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
887
137.27M
94.12%
+111.45K
2025Q3
908
137.16M
94.45%
+8.73M
2025Q2
904
127.18M
89.58%
+1.13M
2025Q1
886
125.13M
85.85%
-5.11M
2024Q4
855
125.47M
82.99%
+4.02M
2024Q3
812
120.93M
80.76%
+2.25M
2024Q2
782
118.65M
76.64%
+5.15M
2024Q1
766
113.09M
82.81%
-916.64K
2023Q4
748
112.27M
83.16%
-472.55K
2023Q3
723
112.40M
83.64%
-8.12M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Laukien (Frank H)
40.41M
26.64%
+31.93K
+0.08%
Aug 15, 2025
Orbis Investment Management Ltd.
4.68M
3.08%
+4.68M
--
Jun 30, 2025
Fidelity Management & Research Company LLC
7.47M
4.92%
-2.35M
-23.89%
Jun 30, 2025
The Vanguard Group, Inc.
10.40M
6.86%
-122.86K
-1.17%
Jun 30, 2025
Pallas Capital Advisors LLC
9.50M
6.26%
+5.56K
+0.06%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.40M
6.2%
-803.98K
-7.88%
Jun 30, 2025
Laukien (Joerg C)
7.52M
4.95%
--
--
Apr 01, 2025
T. Rowe Price Investment Management, Inc.
11.43M
7.53%
-952.71K
-7.69%
Jun 30, 2025
State Street Investment Management (US)
3.78M
2.49%
-42.78K
-1.12%
Jun 30, 2025
Edmond de Rothschild Asset Management (France) S.A.
1.51M
0.99%
+1.51M
--
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
First Trust NYSE Arca Biotechnology Index Fund
3.71%
ProShares Nanotechnology ETF
3.34%
State Street SPDR S&P Kensho Future Security ETF
1.27%
Ballast Small/Mid Cap ETF
1.13%
AB Disruptors ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
0.57%
iShares Health Innovation Active ETF
0.4%
iShares Biotechnology ETF
0.36%
JPMorgan Active Small Cap Value ETF
0.31%
Mehr Anzeigen
First Trust NYSE Arca Biotechnology Index Fund
Anteil3.71%
ProShares Nanotechnology ETF
Anteil3.34%
State Street SPDR S&P Kensho Future Security ETF
Anteil1.27%
Ballast Small/Mid Cap ETF
Anteil1.13%
AB Disruptors ETF
Anteil0.63%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.57%
iShares Health Innovation Active ETF
Anteil0.4%
iShares Biotechnology ETF
Anteil0.36%
JPMorgan Active Small Cap Value ETF
Anteil0.31%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
138.20M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 04, 2025
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025
Dec 08, 2025
Jan 02, 2026
Dec 08, 2025
Aug 12, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025
Sep 23, 2025
Oct 03, 2025
Sep 23, 2025
May 15, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jun 27, 2025
Jun 16, 2025
Feb 21, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 28, 2025
Mar 17, 2025
Nov 18, 2024
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024
Dec 02, 2024
Dec 16, 2024
Dec 02, 2024
Aug 14, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024
Sep 02, 2024
Sep 16, 2024
Aug 30, 2024
May 15, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024
Jun 03, 2024
Jun 17, 2024
Jun 03, 2024
Feb 16, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 20, 2023
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
Aug 14, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 15, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 15, 2023
Aug 31, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Bruker Corp?
Die fünf größten Anteilseigner von Bruker Corp sind:
Laukien (Frank H) hält 40.41M Aktien, was 26.64% der Gesamtaktien entspricht.
Orbis Investment Management Ltd. hält 4.68M Aktien, was 3.08% der Gesamtaktien entspricht.
Fidelity Management & Research Company LLC hält 7.47M Aktien, was 4.92% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 10.40M Aktien, was 6.86% der Gesamtaktien entspricht.
Pallas Capital Advisors LLC hält 9.50M Aktien, was 6.26% der Gesamtaktien entspricht.
Laukien (Frank H) hält 40.41M Aktien, was 26.64% der Gesamtaktien entspricht.
Orbis Investment Management Ltd. hält 4.68M Aktien, was 3.08% der Gesamtaktien entspricht.
Fidelity Management & Research Company LLC hält 7.47M Aktien, was 4.92% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 10.40M Aktien, was 6.86% der Gesamtaktien entspricht.
Pallas Capital Advisors LLC hält 9.50M Aktien, was 6.26% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Bruker Corp?
Die drei wichtigsten Anteilseigner-Typen von Bruker Corp sind:
Laukien (Frank H)
Orbis Investment Management Ltd.
Fidelity Management & Research Company LLC
Laukien (Frank H)
Orbis Investment Management Ltd.
Fidelity Management & Research Company LLC
Wie viele Institutionen halten Anteile an Bruker Corp (BRKR)?
Mit Stand vom 2025Q4 halten 887 Institutionen Anteile an Bruker Corp, mit einem Gesamtmarktwert von etwa 137.27M, was 94.12% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -0.33% gestiegen.
Was ist die größte Einnahmequelle von Bruker Corp?
Am FY2025Q2 erzielte das Geschäft mit Product für Bruker Corp den höchsten Umsatz in Höhe von 634.70M, was 79.60% des Gesamtumsatzes entspricht.
